SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-121523
Filing Date
2022-04-27
Accepted
2022-04-27 07:01:31
Documents
5
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d273377ddef14a.htm DEF 14A 771767
2 GRAPHIC g273377g09k74.jpg GRAPHIC 75026
3 GRAPHIC g273377g22s22.jpg GRAPHIC 17288
4 GRAPHIC g273377g23s23.jpg GRAPHIC 48256
5 GRAPHIC g273377g24s24.jpg GRAPHIC 65488
  Complete submission text file 0001193125-22-121523.txt   1057300
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38722 | Film No.: 22856259
SIC: 2836 Biological Products, (No Diagnostic Substances)